| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.42 | 9e-23 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.41 | 1e-14 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.097 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.084 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |